RMC No. 108-2025: Updated VAT-Exempt Drug List for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, Tuberculosis, and High Cholesterol

RMC No. 108-2025 updates the FDA-endorsed VAT-exempt drug list for key illnesses, affecting pharmacies, healthcare firms, and corporate tax teams. Businesses selling, importing, prescribing, purchasing, reimbursing, or accounting for qualified medicines must immediately validate their product master files, invoices, VAT treatment, and reimbursement rules against the updated VAT-exempt drug list endorsed by the Food and […]

RMC No. 131-2024: Updated VAT-Exempt Medicine List for Cancer, Diabetes, and Mental Illness Products

RMC No. 131-2024 updates the VAT-exempt medicine list for cancer, diabetes, and mental illness products, with effectivity tied to FDA publication. Businesses selling, dispensing, importing, distributing, or accounting for qualified medicines must immediately check the latest FDA-published list of VAT-exempt medicines because the VAT exemption under the CREATE Act takes effect based on the FDAโ€™s […]